echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > [Early bird deadline this Friday] IGC’s full lineup of agendas will be launched, and the world’s top experts will gather in the capital of Golden Autumn to explore the new future of immune gene therapy!

    [Early bird deadline this Friday] IGC’s full lineup of agendas will be launched, and the world’s top experts will gather in the capital of Golden Autumn to explore the new future of immune gene therapy!

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As the annual brand event in the field of immune gene and cell therapy, IGC 2021 5th China International Immune Gene and Cell Therapy Forum will be grandly opened in Beijing on September 1-2


    Professor Song Erwei, a clinical oncologist and academician of the Chinese Academy of Sciences, Professor Mark A.


    Organizers: Chinese Society of Bioengineering, Business Map Biomap


    IGC2021 has confirmed heavy guests

    There are three special sessions dedicated to immunity, gene, and cells, specially inviting authoritative supervisors and academicians, internationally renowned scientific research scholars, senior experts/PIs from top universities, and global leaders of leading companies.


    *More heavy guests continue to be updated.


    Scan the two-digit code below, enter the IGC official website and collect it, and check the lineup of big names you want to see in time!

    IGC2021 special and exclusive topics (list)

    Focusing on the path from "laboratory research and development to clinical transformation"; in-depth "tumor immunity, immune regulation and combination therapy, universal/alternative cells, tumor vaccines, AAV gene therapy, gene editing therapy.


    Session: Gene Therapy Innovation and R&D-Selected Topics

    ▪ Review progress of preclinical and clinical evaluation of


    Session: Innovation and R&D of Cellular Immunotherapy-Selected Topics

    ▪ Evaluation and guiding principle analysis of cell therapy non-clinical research and clinical trial technology


    Session: Frontier Immunotherapy R&D and Combination-Selected Topics

    ▪ The next generation of bispecific fusion proteins CD47 and CLTA-4: targeting tumor cells and immune cells


    Get the full agenda of the forum? Welcome to consult the organizer: 180 1793 9885 (same as WeChat)

    Special thanks to the following cooperating units for their strong support


    The early bird discount ends this Friday!

    【Benefit 1】Group purchase benefits, only when the time comes!

    Register before July 30 to enjoy an immediate early bird discount of 500 yuan! Buying tickets for 4 or more people can enjoy a group purchase discount of 35% off the original price!


    [Benefit 2] Surprise linkage!

    Related conference recommendations:


    Participate in IGC 2021 & P4 China 2021 at the same time from now on, you can enjoy a 20% discount on linkage tickets.


    Contact the organizing committee for more forum information


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.